Cooper Creek Partners purchased nearly 4 million shares of The Chemours Company, valued at $63.1 million, representing 1.9% of their reportable assets as of September 30. Chemours, a producer of various chemicals, saw its shares priced at $12.79, down 41% over the past year, underperforming the S&P 500. The company’s recent earnings show signs of stabilization and cash flow generation despite market challenges.

Cooper Creek Partners Management disclosed a new position in The Chemours Company during the third quarter, acquiring nearly 4 million shares valued at $63.1 million, representing 1.9% of the fund’s assets. Chemours posted $1.5 billion in third-quarter revenue, with strengths in certain products offsetting weaknesses. The company’s performance indicates a potential turnaround opportunity for investors, given its valuation and operational improvements.

Chemours, a chemicals company, attracted interest from Cooper Creek Partners, who established a substantial stake in the company during the third quarter. With $1.5 billion in third-quarter revenue and $60 million in net income, Chemours is showing signs of operational stability and positive financial performance. Investors may find potential in Chemours as a turnaround opportunity with a new institutional buyer on board.

Read more at Yahoo Finance: This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs